Event ended

Patient-Focused Drug Development Guidance: Methods to Identify What is Important to Patients and Select, Develop or Modify Fit-for-Purpose Clinical Outcome Assessments


Follow this organizer to stay informed on future events

By United States Food and Drug Administration